nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—ABCC3—lung cancer	0.108	0.3	CbGaD
Indomethacin—UGT1A1—lung cancer	0.0937	0.26	CbGaD
Indomethacin—CXCL8—lung cancer	0.0884	0.245	CbGaD
Indomethacin—ABCC6—Teniposide—lung cancer	0.0433	0.104	CbGbCtD
Indomethacin—PTGS2—lung cancer	0.0258	0.0714	CbGaD
Indomethacin—ALB—lung cancer	0.023	0.0636	CbGaD
Indomethacin—ABCC11—Methotrexate—lung cancer	0.022	0.0525	CbGbCtD
Indomethacin—ABCB1—lung cancer	0.0219	0.0607	CbGaD
Indomethacin—ABCC6—Vinblastine—lung cancer	0.0212	0.0507	CbGbCtD
Indomethacin—ABCC6—Cisplatin—lung cancer	0.0195	0.0465	CbGbCtD
Indomethacin—ABCC6—Etoposide—lung cancer	0.0191	0.0457	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—lung cancer	0.0173	0.0414	CbGbCtD
Indomethacin—CES1—Irinotecan—lung cancer	0.0173	0.0412	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—lung cancer	0.013	0.0312	CbGbCtD
Indomethacin—UGT1A9—Irinotecan—lung cancer	0.0105	0.025	CbGbCtD
Indomethacin—UGT1A1—Erlotinib—lung cancer	0.00949	0.0227	CbGbCtD
Indomethacin—ABCC3—Cisplatin—lung cancer	0.00935	0.0223	CbGbCtD
Indomethacin—ABCC3—Etoposide—lung cancer	0.00918	0.0219	CbGbCtD
Indomethacin—UGT1A1—Irinotecan—lung cancer	0.00857	0.0205	CbGbCtD
Indomethacin—ABCC1—Paclitaxel—lung cancer	0.00714	0.0171	CbGbCtD
Indomethacin—ABCC1—Irinotecan—lung cancer	0.00704	0.0168	CbGbCtD
Indomethacin—UGT1A1—Etoposide—lung cancer	0.00686	0.0164	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—lung cancer	0.00657	0.0157	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—lung cancer	0.00626	0.015	CbGbCtD
Indomethacin—ABCC1—Vinblastine—lung cancer	0.00626	0.015	CbGbCtD
Indomethacin—ALB—Gefitinib—lung cancer	0.00608	0.0145	CbGbCtD
Indomethacin—ABCC3—Methotrexate—lung cancer	0.00607	0.0145	CbGbCtD
Indomethacin—SLCO1B1—Irinotecan—lung cancer	0.00593	0.0142	CbGbCtD
Indomethacin—ABCC1—Etoposide—lung cancer	0.00564	0.0135	CbGbCtD
Indomethacin—ABCC2—Paclitaxel—lung cancer	0.00528	0.0126	CbGbCtD
Indomethacin—ABCC2—Irinotecan—lung cancer	0.00521	0.0125	CbGbCtD
Indomethacin—ABCC1—Docetaxel—lung cancer	0.00516	0.0123	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—lung cancer	0.00498	0.0119	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—lung cancer	0.00475	0.0113	CbGbCtD
Indomethacin—ABCC4—Methotrexate—lung cancer	0.00464	0.0111	CbGbCtD
Indomethacin—ABCC2—Vinblastine—lung cancer	0.00463	0.0111	CbGbCtD
Indomethacin—ABCC2—Cisplatin—lung cancer	0.00425	0.0102	CbGbCtD
Indomethacin—PTGS2—Cisplatin—lung cancer	0.0042	0.01	CbGbCtD
Indomethacin—ABCC2—Etoposide—lung cancer	0.00417	0.00997	CbGbCtD
Indomethacin—PTGS2—Etoposide—lung cancer	0.00412	0.00986	CbGbCtD
Indomethacin—CYP2C19—Gefitinib—lung cancer	0.00394	0.00942	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—lung cancer	0.00385	0.00919	CbGbCtD
Indomethacin—CYP2C19—Teniposide—lung cancer	0.00382	0.00914	CbGbCtD
Indomethacin—ABCC2—Docetaxel—lung cancer	0.00382	0.00913	CbGbCtD
Indomethacin—ABCC1—Methotrexate—lung cancer	0.00373	0.0089	CbGbCtD
Indomethacin—ALB—Erlotinib—lung cancer	0.0036	0.00859	CbGbCtD
Indomethacin—PTGS1—Etoposide—lung cancer	0.00348	0.00832	CbGbCtD
Indomethacin—ABCB1—Topotecan—lung cancer	0.00348	0.00831	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—lung cancer	0.00333	0.00795	CbGbCtD
Indomethacin—CYP2C9—Gefitinib—lung cancer	0.00328	0.00783	CbGbCtD
Indomethacin—ALB—Irinotecan—lung cancer	0.00325	0.00776	CbGbCtD
Indomethacin—ABCB1—Gefitinib—lung cancer	0.00318	0.0076	CbGbCtD
Indomethacin—CYP2C9—Teniposide—lung cancer	0.00318	0.0076	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—lung cancer	0.00314	0.0075	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—lung cancer	0.0029	0.00692	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—lung cancer	0.00285	0.0068	CbGbCtD
Indomethacin—ABCC2—Methotrexate—lung cancer	0.00276	0.00659	CbGbCtD
Indomethacin—ABCB1—Vinorelbine—lung cancer	0.00245	0.00586	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—lung cancer	0.00202	0.00482	CbGbCtD
Indomethacin—ABCC11—mammary gland—lung cancer	0.002	0.0664	CbGeAlD
Indomethacin—ABCB1—Crizotinib—lung cancer	0.00195	0.00466	CbGbCtD
Indomethacin—ABCB1—Gemcitabine—lung cancer	0.00191	0.00455	CbGbCtD
Indomethacin—ABCB1—Erlotinib—lung cancer	0.00188	0.0045	CbGbCtD
Indomethacin—CYP2C9—Paclitaxel—lung cancer	0.00177	0.00424	CbGbCtD
Indomethacin—ABCB1—Paclitaxel—lung cancer	0.00172	0.00411	CbGbCtD
Indomethacin—ALB—Methotrexate—lung cancer	0.00172	0.00411	CbGbCtD
Indomethacin—ABCB1—Irinotecan—lung cancer	0.0017	0.00406	CbGbCtD
Indomethacin—ABCB1—Vinblastine—lung cancer	0.00151	0.00361	CbGbCtD
Indomethacin—CYP2C9—Cisplatin—lung cancer	0.00143	0.00341	CbGbCtD
Indomethacin—ABCB1—Cisplatin—lung cancer	0.00138	0.00331	CbGbCtD
Indomethacin—ABCB1—Etoposide—lung cancer	0.00136	0.00325	CbGbCtD
Indomethacin—GLO1—mammary gland—lung cancer	0.00125	0.0415	CbGeAlD
Indomethacin—ABCB1—Docetaxel—lung cancer	0.00124	0.00297	CbGbCtD
Indomethacin—PTGR2—cardiac atrium—lung cancer	0.000933	0.0311	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—lung cancer	0.000928	0.00222	CbGbCtD
Indomethacin—ABCB1—Methotrexate—lung cancer	0.000899	0.00215	CbGbCtD
Indomethacin—GLO1—respiratory system—lung cancer	0.00083	0.0276	CbGeAlD
Indomethacin—PLA2G2A—respiratory system—lung cancer	0.000772	0.0257	CbGeAlD
Indomethacin—PTGR2—lung—lung cancer	0.000713	0.0238	CbGeAlD
Indomethacin—GLO1—epithelium—lung cancer	0.000694	0.0231	CbGeAlD
Indomethacin—SLCO1B1—mammary gland—lung cancer	0.00069	0.023	CbGeAlD
Indomethacin—GLO1—bronchus—lung cancer	0.000683	0.0227	CbGeAlD
Indomethacin—PLA2G2A—epithelium—lung cancer	0.000645	0.0215	CbGeAlD
Indomethacin—PLA2G2A—bronchus—lung cancer	0.000635	0.0211	CbGeAlD
Indomethacin—CXCL8—bronchus—lung cancer	0.000629	0.0209	CbGeAlD
Indomethacin—GLO1—trachea—lung cancer	0.000613	0.0204	CbGeAlD
Indomethacin—PPARA—epithelium—lung cancer	0.000602	0.0201	CbGeAlD
Indomethacin—PPARG—mammary gland—lung cancer	0.000595	0.0198	CbGeAlD
Indomethacin—GLO1—cardiac atrium—lung cancer	0.000576	0.0192	CbGeAlD
Indomethacin—PLA2G2A—trachea—lung cancer	0.00057	0.019	CbGeAlD
Indomethacin—CXCL8—trachea—lung cancer	0.000565	0.0188	CbGeAlD
Indomethacin—ALB—mammary gland—lung cancer	0.000558	0.0186	CbGeAlD
Indomethacin—Tolmetin—CXCL8—lung cancer	0.000547	0.301	CrCbGaD
Indomethacin—PLA2G2A—cardiac atrium—lung cancer	0.000536	0.0178	CbGeAlD
Indomethacin—CES1—respiratory system—lung cancer	0.000535	0.0178	CbGeAlD
Indomethacin—AKR1C3—bronchus—lung cancer	0.000493	0.0164	CbGeAlD
Indomethacin—PTGR2—lymph node—lung cancer	0.000488	0.0162	CbGeAlD
Indomethacin—GLO1—bone marrow—lung cancer	0.000486	0.0162	CbGeAlD
Indomethacin—CXCL8—bone marrow—lung cancer	0.000448	0.0149	CbGeAlD
Indomethacin—AKR1C3—trachea—lung cancer	0.000443	0.0147	CbGeAlD
Indomethacin—GLO1—lung—lung cancer	0.000441	0.0147	CbGeAlD
Indomethacin—Naproxen—UGT1A1—lung cancer	0.000436	0.24	CrCbGaD
Indomethacin—ABCC3—respiratory system—lung cancer	0.000436	0.0145	CbGeAlD
Indomethacin—AKR1C3—cardiac atrium—lung cancer	0.000416	0.0138	CbGeAlD
Indomethacin—PLA2G2A—lung—lung cancer	0.00041	0.0136	CbGeAlD
Indomethacin—ABCC6—lung—lung cancer	0.000406	0.0135	CbGeAlD
Indomethacin—CXCL8—lung—lung cancer	0.000406	0.0135	CbGeAlD
Indomethacin—PPARG—respiratory system—lung cancer	0.000396	0.0132	CbGeAlD
Indomethacin—PPARA—lung—lung cancer	0.000383	0.0127	CbGeAlD
Indomethacin—ABCC6—Podofilox—Teniposide—lung cancer	0.000381	0.154	CbGdCrCtD
Indomethacin—AKR1C3—bone marrow—lung cancer	0.000351	0.0117	CbGeAlD
Indomethacin—CYP2C9—mammary gland—lung cancer	0.000348	0.0116	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Teniposide—lung cancer	0.000333	0.134	CbGdCrCtD
Indomethacin—PPARG—epithelium—lung cancer	0.000331	0.011	CbGeAlD
Indomethacin—AKR1C3—lung—lung cancer	0.000318	0.0106	CbGeAlD
Indomethacin—GLO1—lymph node—lung cancer	0.000301	0.01	CbGeAlD
Indomethacin—ABCC4—bronchus—lung cancer	0.000296	0.00986	CbGeAlD
Indomethacin—CES1—lung—lung cancer	0.000284	0.00946	CbGeAlD
Indomethacin—PLA2G2A—lymph node—lung cancer	0.00028	0.00933	CbGeAlD
Indomethacin—CXCL8—lymph node—lung cancer	0.000277	0.00924	CbGeAlD
Indomethacin—PPARA—lymph node—lung cancer	0.000262	0.00871	CbGeAlD
Indomethacin—PPARG—Irinotecan—Topotecan—lung cancer	0.00026	0.105	CbGdCrCtD
Indomethacin—ABCC1—bronchus—lung cancer	0.000253	0.00841	CbGeAlD
Indomethacin—Bromfenac—PTGS2—lung cancer	0.000237	0.131	CrCbGaD
Indomethacin—PPARG—bone marrow—lung cancer	0.000232	0.00773	CbGeAlD
Indomethacin—ABCC3—lung—lung cancer	0.000232	0.00771	CbGeAlD
Indomethacin—ABCC1—trachea—lung cancer	0.000227	0.00755	CbGeAlD
Indomethacin—ABCC6—Podofilox—Etoposide—lung cancer	0.000226	0.0914	CbGdCrCtD
Indomethacin—AKR1C3—lymph node—lung cancer	0.000217	0.00724	CbGeAlD
Indomethacin—PPARG—Topotecan—Irinotecan—lung cancer	0.000216	0.0872	CbGdCrCtD
Indomethacin—PPARG—Etoposide—Teniposide—lung cancer	0.000215	0.0866	CbGdCrCtD
Indomethacin—ABCC1—cardiac atrium—lung cancer	0.000213	0.00709	CbGeAlD
Indomethacin—PTGS1—respiratory system—lung cancer	0.000212	0.00705	CbGeAlD
Indomethacin—AKR1C3—Vincristine—Vinorelbine—lung cancer	0.000212	0.0855	CbGdCrCtD
Indomethacin—ABCC4—bone marrow—lung cancer	0.000211	0.00702	CbGeAlD
Indomethacin—PPARG—lung—lung cancer	0.00021	0.00701	CbGeAlD
Indomethacin—Bezafibrate—CYP1A1—lung cancer	0.00021	0.116	CrCbGaD
Indomethacin—PTGS2—respiratory system—lung cancer	0.000203	0.00674	CbGeAlD
Indomethacin—SLCO1A2—lung—lung cancer	0.000199	0.00661	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Etoposide—lung cancer	0.000198	0.0799	CbGdCrCtD
Indomethacin—CES1—lymph node—lung cancer	0.000194	0.00647	CbGeAlD
Indomethacin—ABCC4—lung—lung cancer	0.000191	0.00636	CbGeAlD
Indomethacin—PTGS1—epithelium—lung cancer	0.000177	0.0059	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vinorelbine—lung cancer	0.00017	0.0688	CbGdCrCtD
Indomethacin—AKR1C3—Vincristine—Vinblastine—lung cancer	0.000169	0.0684	CbGdCrCtD
Indomethacin—PTGS2—epithelium—lung cancer	0.000169	0.00563	CbGeAlD
Indomethacin—PTGS2—bronchus—lung cancer	0.000167	0.00555	CbGeAlD
Indomethacin—ABCC1—lung—lung cancer	0.000163	0.00542	CbGeAlD
Indomethacin—Tolmetin—PTGS2—lung cancer	0.00016	0.0878	CrCbGaD
Indomethacin—ABCC3—lymph node—lung cancer	0.000158	0.00527	CbGeAlD
Indomethacin—PTGS1—trachea—lung cancer	0.000157	0.00521	CbGeAlD
Indomethacin—PTGS2—trachea—lung cancer	0.00015	0.00498	CbGeAlD
Indomethacin—PTGS1—cardiac atrium—lung cancer	0.000147	0.0049	CbGeAlD
Indomethacin—PPARG—lymph node—lung cancer	0.000144	0.00479	CbGeAlD
Indomethacin—ALB—lymph node—lung cancer	0.000135	0.0045	CbGeAlD
Indomethacin—ABCC4—lymph node—lung cancer	0.000131	0.00435	CbGeAlD
Indomethacin—ABCC2—lymph node—lung cancer	0.000127	0.00421	CbGeAlD
Indomethacin—ABCB1—respiratory system—lung cancer	0.000125	0.00417	CbGeAlD
Indomethacin—Naproxen—PTGS2—lung cancer	0.00012	0.0661	CrCbGaD
Indomethacin—PTGS2—bone marrow—lung cancer	0.000119	0.00395	CbGeAlD
Indomethacin—PTGS1—lung—lung cancer	0.000113	0.00375	CbGeAlD
Indomethacin—ABCC1—lymph node—lung cancer	0.000111	0.00371	CbGeAlD
Indomethacin—PTGS2—lung—lung cancer	0.000108	0.00358	CbGeAlD
Indomethacin—Naproxen—ALB—lung cancer	0.000107	0.0588	CrCbGaD
Indomethacin—ABCB1—epithelium—lung cancer	0.000105	0.00349	CbGeAlD
Indomethacin—PPARG—Teniposide—Etoposide—lung cancer	9.73e-05	0.0393	CbGdCrCtD
Indomethacin—ABCB1—trachea—lung cancer	9.26e-05	0.00308	CbGeAlD
Indomethacin—PTGS1—lymph node—lung cancer	7.7e-05	0.00256	CbGeAlD
Indomethacin—PTGS2—lymph node—lung cancer	7.36e-05	0.00245	CbGeAlD
Indomethacin—ABCB1—bone marrow—lung cancer	7.34e-05	0.00244	CbGeAlD
Indomethacin—ABCB1—lung—lung cancer	6.65e-05	0.00221	CbGeAlD
Indomethacin—ABCB1—lymph node—lung cancer	4.55e-05	0.00151	CbGeAlD
Indomethacin—Anorexia—Paclitaxel—lung cancer	4.16e-05	0.000431	CcSEcCtD
Indomethacin—Hypotension—Etoposide—lung cancer	4.16e-05	0.000431	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—lung cancer	4.15e-05	0.00043	CcSEcCtD
Indomethacin—Pain—Cisplatin—lung cancer	4.15e-05	0.00043	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Methotrexate—lung cancer	4.14e-05	0.000429	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—lung cancer	4.14e-05	0.000429	CcSEcCtD
Indomethacin—Vomiting—Vinorelbine—lung cancer	4.12e-05	0.000427	CcSEcCtD
Indomethacin—Body temperature increased—Gemcitabine—lung cancer	4.12e-05	0.000427	CcSEcCtD
Indomethacin—Renal failure—Methotrexate—lung cancer	4.11e-05	0.000426	CcSEcCtD
Indomethacin—Rash—Vinorelbine—lung cancer	4.09e-05	0.000424	CcSEcCtD
Indomethacin—Dermatitis—Vinorelbine—lung cancer	4.08e-05	0.000423	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—lung cancer	4.08e-05	0.000423	CcSEcCtD
Indomethacin—Hypotension—Paclitaxel—lung cancer	4.07e-05	0.000422	CcSEcCtD
Indomethacin—Stomatitis—Methotrexate—lung cancer	4.07e-05	0.000422	CcSEcCtD
Indomethacin—Headache—Vinorelbine—lung cancer	4.06e-05	0.000421	CcSEcCtD
Indomethacin—Syncope—Docetaxel—lung cancer	4.06e-05	0.000421	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—lung cancer	4.06e-05	0.00042	CcSEcCtD
Indomethacin—Leukopenia—Docetaxel—lung cancer	4.05e-05	0.00042	CcSEcCtD
Indomethacin—Sweating—Methotrexate—lung cancer	4e-05	0.000415	CcSEcCtD
Indomethacin—Palpitations—Docetaxel—lung cancer	4e-05	0.000415	CcSEcCtD
Indomethacin—Feeling abnormal—Cisplatin—lung cancer	4e-05	0.000415	CcSEcCtD
Indomethacin—Paraesthesia—Etoposide—lung cancer	3.99e-05	0.000414	CcSEcCtD
Indomethacin—Haematuria—Methotrexate—lung cancer	3.98e-05	0.000413	CcSEcCtD
Indomethacin—Loss of consciousness—Docetaxel—lung cancer	3.98e-05	0.000413	CcSEcCtD
Indomethacin—Dyspnoea—Etoposide—lung cancer	3.96e-05	0.000411	CcSEcCtD
Indomethacin—Somnolence—Etoposide—lung cancer	3.95e-05	0.00041	CcSEcCtD
Indomethacin—Insomnia—Paclitaxel—lung cancer	3.94e-05	0.000409	CcSEcCtD
Indomethacin—Epistaxis—Methotrexate—lung cancer	3.94e-05	0.000408	CcSEcCtD
Indomethacin—Hypersensitivity—Irinotecan—lung cancer	3.94e-05	0.000408	CcSEcCtD
Indomethacin—Convulsion—Docetaxel—lung cancer	3.92e-05	0.000407	CcSEcCtD
Indomethacin—Paraesthesia—Paclitaxel—lung cancer	3.92e-05	0.000406	CcSEcCtD
Indomethacin—Hypertension—Docetaxel—lung cancer	3.91e-05	0.000405	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—lung cancer	3.9e-05	0.000404	CcSEcCtD
Indomethacin—Dyspnoea—Paclitaxel—lung cancer	3.89e-05	0.000403	CcSEcCtD
Indomethacin—Somnolence—Paclitaxel—lung cancer	3.88e-05	0.000402	CcSEcCtD
Indomethacin—Decreased appetite—Etoposide—lung cancer	3.87e-05	0.000401	CcSEcCtD
Indomethacin—Chest pain—Docetaxel—lung cancer	3.86e-05	0.0004	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—lung cancer	3.85e-05	0.000399	CcSEcCtD
Indomethacin—Nausea—Vinorelbine—lung cancer	3.85e-05	0.000399	CcSEcCtD
Indomethacin—Dyspepsia—Paclitaxel—lung cancer	3.84e-05	0.000398	CcSEcCtD
Indomethacin—Body temperature increased—Cisplatin—lung cancer	3.84e-05	0.000398	CcSEcCtD
Indomethacin—Asthenia—Irinotecan—lung cancer	3.84e-05	0.000398	CcSEcCtD
Indomethacin—Fatigue—Etoposide—lung cancer	3.83e-05	0.000397	CcSEcCtD
Indomethacin—Constipation—Etoposide—lung cancer	3.8e-05	0.000394	CcSEcCtD
Indomethacin—Pain—Etoposide—lung cancer	3.8e-05	0.000394	CcSEcCtD
Indomethacin—Decreased appetite—Paclitaxel—lung cancer	3.79e-05	0.000393	CcSEcCtD
Indomethacin—Haemoglobin—Methotrexate—lung cancer	3.77e-05	0.000391	CcSEcCtD
Indomethacin—Fatigue—Paclitaxel—lung cancer	3.76e-05	0.00039	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—lung cancer	3.75e-05	0.000389	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—lung cancer	3.75e-05	0.000389	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—lung cancer	3.75e-05	0.000388	CcSEcCtD
Indomethacin—Asthenia—Gemcitabine—lung cancer	3.74e-05	0.000387	CcSEcCtD
Indomethacin—Constipation—Paclitaxel—lung cancer	3.73e-05	0.000386	CcSEcCtD
Indomethacin—Pain—Paclitaxel—lung cancer	3.73e-05	0.000386	CcSEcCtD
Indomethacin—Confusional state—Docetaxel—lung cancer	3.73e-05	0.000386	CcSEcCtD
Indomethacin—Anaphylactic shock—Docetaxel—lung cancer	3.7e-05	0.000383	CcSEcCtD
Indomethacin—Oedema—Docetaxel—lung cancer	3.7e-05	0.000383	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—lung cancer	3.69e-05	0.000383	CcSEcCtD
Indomethacin—Pruritus—Gemcitabine—lung cancer	3.68e-05	0.000382	CcSEcCtD
Indomethacin—Feeling abnormal—Etoposide—lung cancer	3.66e-05	0.00038	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—lung cancer	3.66e-05	0.000379	CcSEcCtD
Indomethacin—Diarrhoea—Irinotecan—lung cancer	3.66e-05	0.000379	CcSEcCtD
Indomethacin—Gastrointestinal pain—Etoposide—lung cancer	3.64e-05	0.000377	CcSEcCtD
Indomethacin—Shock—Docetaxel—lung cancer	3.64e-05	0.000377	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—lung cancer	3.62e-05	0.000375	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—lung cancer	3.62e-05	0.000375	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—lung cancer	3.61e-05	0.000374	CcSEcCtD
Indomethacin—Feeling abnormal—Paclitaxel—lung cancer	3.59e-05	0.000372	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.59e-05	0.000372	CcSEcCtD
Indomethacin—Hypersensitivity—Cisplatin—lung cancer	3.58e-05	0.000371	CcSEcCtD
Indomethacin—Gastrointestinal pain—Paclitaxel—lung cancer	3.57e-05	0.00037	CcSEcCtD
Indomethacin—Diarrhoea—Gemcitabine—lung cancer	3.56e-05	0.000369	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—lung cancer	3.56e-05	0.000368	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—lung cancer	3.55e-05	0.000367	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—lung cancer	3.55e-05	0.000367	CcSEcCtD
Indomethacin—Dizziness—Irinotecan—lung cancer	3.54e-05	0.000366	CcSEcCtD
Indomethacin—Urticaria—Etoposide—lung cancer	3.53e-05	0.000366	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—lung cancer	3.53e-05	0.000365	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—lung cancer	3.53e-05	0.000365	CcSEcCtD
Indomethacin—Anorexia—Docetaxel—lung cancer	3.52e-05	0.000365	CcSEcCtD
Indomethacin—Abdominal pain—Etoposide—lung cancer	3.52e-05	0.000364	CcSEcCtD
Indomethacin—Body temperature increased—Etoposide—lung cancer	3.52e-05	0.000364	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—lung cancer	3.5e-05	0.000362	CcSEcCtD
Indomethacin—Asthenia—Cisplatin—lung cancer	3.48e-05	0.000361	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—lung cancer	3.47e-05	0.000359	CcSEcCtD
Indomethacin—Urticaria—Paclitaxel—lung cancer	3.46e-05	0.000359	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—lung cancer	3.45e-05	0.000358	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—lung cancer	3.45e-05	0.000357	CcSEcCtD
Indomethacin—Abdominal pain—Paclitaxel—lung cancer	3.45e-05	0.000357	CcSEcCtD
Indomethacin—Body temperature increased—Paclitaxel—lung cancer	3.45e-05	0.000357	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—lung cancer	3.41e-05	0.000354	CcSEcCtD
Indomethacin—Vomiting—Irinotecan—lung cancer	3.4e-05	0.000352	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—lung cancer	3.37e-05	0.00035	CcSEcCtD
Indomethacin—Rash—Irinotecan—lung cancer	3.37e-05	0.000349	CcSEcCtD
Indomethacin—Dermatitis—Irinotecan—lung cancer	3.37e-05	0.000349	CcSEcCtD
Indomethacin—Headache—Irinotecan—lung cancer	3.35e-05	0.000347	CcSEcCtD
Indomethacin—Insomnia—Docetaxel—lung cancer	3.34e-05	0.000346	CcSEcCtD
Indomethacin—Diarrhoea—Cisplatin—lung cancer	3.32e-05	0.000344	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—lung cancer	3.32e-05	0.000344	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—lung cancer	3.31e-05	0.000343	CcSEcCtD
Indomethacin—Vomiting—Gemcitabine—lung cancer	3.31e-05	0.000343	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—lung cancer	3.31e-05	0.000343	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—lung cancer	3.29e-05	0.000342	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—lung cancer	3.29e-05	0.000341	CcSEcCtD
Indomethacin—Rash—Gemcitabine—lung cancer	3.28e-05	0.00034	CcSEcCtD
Indomethacin—Dermatitis—Gemcitabine—lung cancer	3.28e-05	0.00034	CcSEcCtD
Indomethacin—Hypersensitivity—Etoposide—lung cancer	3.28e-05	0.00034	CcSEcCtD
Indomethacin—Erythema—Methotrexate—lung cancer	3.26e-05	0.000338	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—lung cancer	3.26e-05	0.000338	CcSEcCtD
Indomethacin—Headache—Gemcitabine—lung cancer	3.26e-05	0.000338	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—lung cancer	3.25e-05	0.000337	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—lung cancer	3.25e-05	0.000336	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—lung cancer	3.25e-05	0.000336	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—lung cancer	3.21e-05	0.000333	CcSEcCtD
Indomethacin—Hypersensitivity—Paclitaxel—lung cancer	3.21e-05	0.000333	CcSEcCtD
Indomethacin—Asthenia—Etoposide—lung cancer	3.19e-05	0.000331	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—lung cancer	3.19e-05	0.00033	CcSEcCtD
Indomethacin—Nausea—Irinotecan—lung cancer	3.18e-05	0.000329	CcSEcCtD
Indomethacin—Constipation—Docetaxel—lung cancer	3.16e-05	0.000328	CcSEcCtD
Indomethacin—Pain—Docetaxel—lung cancer	3.16e-05	0.000328	CcSEcCtD
Indomethacin—Pruritus—Etoposide—lung cancer	3.15e-05	0.000326	CcSEcCtD
Indomethacin—Asthenia—Paclitaxel—lung cancer	3.13e-05	0.000324	CcSEcCtD
Indomethacin—Nausea—Gemcitabine—lung cancer	3.09e-05	0.000321	CcSEcCtD
Indomethacin—Vomiting—Cisplatin—lung cancer	3.09e-05	0.00032	CcSEcCtD
Indomethacin—Pruritus—Paclitaxel—lung cancer	3.08e-05	0.00032	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—lung cancer	3.08e-05	0.000319	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—lung cancer	3.07e-05	0.000318	CcSEcCtD
Indomethacin—Rash—Cisplatin—lung cancer	3.06e-05	0.000317	CcSEcCtD
Indomethacin—Dermatitis—Cisplatin—lung cancer	3.06e-05	0.000317	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—lung cancer	3.05e-05	0.000316	CcSEcCtD
Indomethacin—Diarrhoea—Etoposide—lung cancer	3.04e-05	0.000315	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—lung cancer	3.03e-05	0.000314	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—lung cancer	3.03e-05	0.000314	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—lung cancer	3.02e-05	0.000313	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—lung cancer	3.02e-05	0.000313	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—lung cancer	3.01e-05	0.000312	CcSEcCtD
Indomethacin—Diarrhoea—Paclitaxel—lung cancer	2.98e-05	0.000309	CcSEcCtD
Indomethacin—Malaise—Methotrexate—lung cancer	2.94e-05	0.000305	CcSEcCtD
Indomethacin—Dizziness—Etoposide—lung cancer	2.94e-05	0.000305	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—lung cancer	2.93e-05	0.000304	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—lung cancer	2.92e-05	0.000303	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—lung cancer	2.92e-05	0.000303	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—lung cancer	2.92e-05	0.000303	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—lung cancer	2.9e-05	0.000301	CcSEcCtD
Indomethacin—Dizziness—Paclitaxel—lung cancer	2.88e-05	0.000299	CcSEcCtD
Indomethacin—Nausea—Cisplatin—lung cancer	2.88e-05	0.000299	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—lung cancer	2.87e-05	0.000297	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—lung cancer	2.83e-05	0.000293	CcSEcCtD
Indomethacin—Vomiting—Etoposide—lung cancer	2.83e-05	0.000293	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—lung cancer	2.83e-05	0.000293	CcSEcCtD
Indomethacin—Rash—Etoposide—lung cancer	2.8e-05	0.000291	CcSEcCtD
Indomethacin—Dermatitis—Etoposide—lung cancer	2.8e-05	0.00029	CcSEcCtD
Indomethacin—Headache—Etoposide—lung cancer	2.79e-05	0.000289	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—lung cancer	2.78e-05	0.000289	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—lung cancer	2.78e-05	0.000288	CcSEcCtD
Indomethacin—Tension—Doxorubicin—lung cancer	2.77e-05	0.000287	CcSEcCtD
Indomethacin—Vomiting—Paclitaxel—lung cancer	2.77e-05	0.000287	CcSEcCtD
Indomethacin—Rash—Paclitaxel—lung cancer	2.75e-05	0.000285	CcSEcCtD
Indomethacin—Dermatitis—Paclitaxel—lung cancer	2.75e-05	0.000285	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—lung cancer	2.75e-05	0.000285	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—lung cancer	2.74e-05	0.000284	CcSEcCtD
Indomethacin—Headache—Paclitaxel—lung cancer	2.73e-05	0.000283	CcSEcCtD
Indomethacin—Hypersensitivity—Docetaxel—lung cancer	2.72e-05	0.000282	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—lung cancer	2.69e-05	0.000278	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—lung cancer	2.66e-05	0.000276	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—lung cancer	2.66e-05	0.000276	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—lung cancer	2.65e-05	0.000275	CcSEcCtD
Indomethacin—Nausea—Etoposide—lung cancer	2.64e-05	0.000274	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—lung cancer	2.62e-05	0.000272	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—lung cancer	2.61e-05	0.000271	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—lung cancer	2.61e-05	0.000271	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—lung cancer	2.61e-05	0.00027	CcSEcCtD
Indomethacin—Nausea—Paclitaxel—lung cancer	2.59e-05	0.000268	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—lung cancer	2.58e-05	0.000267	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—lung cancer	2.55e-05	0.000264	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—lung cancer	2.54e-05	0.000263	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—lung cancer	2.54e-05	0.000263	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—lung cancer	2.53e-05	0.000263	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—lung cancer	2.53e-05	0.000262	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—lung cancer	2.53e-05	0.000262	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—lung cancer	2.5e-05	0.000259	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—lung cancer	2.49e-05	0.000258	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—lung cancer	2.48e-05	0.000257	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—lung cancer	2.45e-05	0.000254	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—lung cancer	2.44e-05	0.000253	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—lung cancer	2.44e-05	0.000253	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—lung cancer	2.41e-05	0.00025	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—lung cancer	2.41e-05	0.000249	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—lung cancer	2.4e-05	0.000249	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—lung cancer	2.39e-05	0.000248	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—lung cancer	2.38e-05	0.000246	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—lung cancer	2.37e-05	0.000246	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—lung cancer	2.37e-05	0.000245	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—lung cancer	2.35e-05	0.000244	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—lung cancer	2.34e-05	0.000243	CcSEcCtD
Indomethacin—Rash—Docetaxel—lung cancer	2.33e-05	0.000242	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—lung cancer	2.33e-05	0.000241	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—lung cancer	2.33e-05	0.000241	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—lung cancer	2.32e-05	0.00024	CcSEcCtD
Indomethacin—Headache—Docetaxel—lung cancer	2.32e-05	0.00024	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—lung cancer	2.31e-05	0.000239	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—lung cancer	2.31e-05	0.000239	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—lung cancer	2.3e-05	0.000238	CcSEcCtD
Indomethacin—Pain—Methotrexate—lung cancer	2.28e-05	0.000236	CcSEcCtD
Indomethacin—Shock—Doxorubicin—lung cancer	2.27e-05	0.000235	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—lung cancer	2.26e-05	0.000234	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—lung cancer	2.25e-05	0.000233	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—lung cancer	2.23e-05	0.000231	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—lung cancer	2.2e-05	0.000228	CcSEcCtD
Indomethacin—Nausea—Docetaxel—lung cancer	2.2e-05	0.000228	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—lung cancer	2.2e-05	0.000228	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—lung cancer	2.18e-05	0.000226	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—lung cancer	2.16e-05	0.000223	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—lung cancer	2.12e-05	0.000219	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—lung cancer	2.11e-05	0.000218	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—lung cancer	2.11e-05	0.000218	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—lung cancer	2.09e-05	0.000216	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—lung cancer	2.07e-05	0.000215	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—lung cancer	2.06e-05	0.000213	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—lung cancer	2.05e-05	0.000213	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—lung cancer	2.03e-05	0.00021	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—lung cancer	2.01e-05	0.000208	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—lung cancer	1.99e-05	0.000206	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—lung cancer	1.97e-05	0.000204	CcSEcCtD
Indomethacin—Pain—Doxorubicin—lung cancer	1.97e-05	0.000204	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—lung cancer	1.96e-05	0.000203	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—lung cancer	1.91e-05	0.000198	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—lung cancer	1.9e-05	0.000197	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—lung cancer	1.89e-05	0.000195	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—lung cancer	1.88e-05	0.000195	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—lung cancer	1.83e-05	0.00019	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—lung cancer	1.82e-05	0.000189	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—lung cancer	1.82e-05	0.000189	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—lung cancer	1.82e-05	0.000189	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—lung cancer	1.76e-05	0.000183	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—lung cancer	1.7e-05	0.000176	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—lung cancer	1.69e-05	0.000176	CcSEcCtD
Indomethacin—Rash—Methotrexate—lung cancer	1.68e-05	0.000174	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—lung cancer	1.68e-05	0.000174	CcSEcCtD
Indomethacin—Headache—Methotrexate—lung cancer	1.67e-05	0.000173	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—lung cancer	1.65e-05	0.000172	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—lung cancer	1.63e-05	0.000169	CcSEcCtD
Indomethacin—Nausea—Methotrexate—lung cancer	1.58e-05	0.000164	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—lung cancer	1.58e-05	0.000164	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—lung cancer	1.53e-05	0.000158	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—lung cancer	1.47e-05	0.000152	CcSEcCtD
Indomethacin—Rash—Doxorubicin—lung cancer	1.45e-05	0.000151	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—lung cancer	1.45e-05	0.000151	CcSEcCtD
Indomethacin—Headache—Doxorubicin—lung cancer	1.44e-05	0.00015	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—lung cancer	1.37e-05	0.000142	CcSEcCtD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.51e-06	1.68e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—lung cancer	1.5e-06	1.68e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—STK11—lung cancer	1.5e-06	1.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP1A1—lung cancer	1.49e-06	1.67e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NQO1—lung cancer	1.49e-06	1.66e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—lung cancer	1.49e-06	1.66e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—lung cancer	1.49e-06	1.66e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CB—lung cancer	1.48e-06	1.66e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1A—lung cancer	1.48e-06	1.65e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ERCC2—lung cancer	1.48e-06	1.65e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—lung cancer	1.48e-06	1.65e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—EP300—lung cancer	1.47e-06	1.64e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CG—lung cancer	1.47e-06	1.64e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2E1—lung cancer	1.47e-06	1.64e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—lung cancer	1.47e-06	1.64e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—lung cancer	1.47e-06	1.64e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—lung cancer	1.47e-06	1.64e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.46e-06	1.63e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NQO1—lung cancer	1.46e-06	1.62e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CD—lung cancer	1.45e-06	1.62e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.45e-06	1.62e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—lung cancer	1.44e-06	1.61e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—lung cancer	1.44e-06	1.61e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—lung cancer	1.44e-06	1.61e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—lung cancer	1.44e-06	1.6e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—lung cancer	1.43e-06	1.6e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—lung cancer	1.41e-06	1.57e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.41e-06	1.57e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—lung cancer	1.4e-06	1.57e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—lung cancer	1.4e-06	1.57e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—POMC—lung cancer	1.4e-06	1.56e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—lung cancer	1.4e-06	1.56e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—lung cancer	1.4e-06	1.56e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—lung cancer	1.39e-06	1.56e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—lung cancer	1.39e-06	1.55e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.39e-06	1.55e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—lung cancer	1.39e-06	1.55e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—lung cancer	1.38e-06	1.54e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—lung cancer	1.38e-06	1.54e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—lung cancer	1.38e-06	1.54e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGF—lung cancer	1.38e-06	1.54e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—lung cancer	1.38e-06	1.54e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—lung cancer	1.38e-06	1.54e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2E1—lung cancer	1.38e-06	1.54e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—lung cancer	1.37e-06	1.53e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—lung cancer	1.37e-06	1.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—lung cancer	1.37e-06	1.53e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—lung cancer	1.37e-06	1.53e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CREBBP—lung cancer	1.37e-06	1.52e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NQO1—lung cancer	1.36e-06	1.52e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAT—lung cancer	1.35e-06	1.51e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—STK11—lung cancer	1.34e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.34e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—lung cancer	1.33e-06	1.49e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—lung cancer	1.33e-06	1.49e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.33e-06	1.49e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—lung cancer	1.33e-06	1.48e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—lung cancer	1.32e-06	1.48e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—lung cancer	1.32e-06	1.47e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—lung cancer	1.32e-06	1.47e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.32e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—lung cancer	1.32e-06	1.47e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—lung cancer	1.32e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—lung cancer	1.31e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—STK11—lung cancer	1.31e-06	1.46e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—lung cancer	1.31e-06	1.46e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—lung cancer	1.31e-06	1.46e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6R—lung cancer	1.3e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—lung cancer	1.29e-06	1.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CREBBP—lung cancer	1.29e-06	1.44e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—lung cancer	1.29e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—lung cancer	1.29e-06	1.44e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—lung cancer	1.28e-06	1.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOA1—lung cancer	1.28e-06	1.43e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—lung cancer	1.28e-06	1.43e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—lung cancer	1.28e-06	1.43e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—lung cancer	1.28e-06	1.43e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—lung cancer	1.27e-06	1.42e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—lung cancer	1.27e-06	1.42e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—lung cancer	1.26e-06	1.41e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.26e-06	1.41e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—lung cancer	1.26e-06	1.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—lung cancer	1.24e-06	1.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAP2K1—lung cancer	1.23e-06	1.38e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—lung cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—lung cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—lung cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—lung cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—STK11—lung cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—lung cancer	1.22e-06	1.36e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—lung cancer	1.22e-06	1.36e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—lung cancer	1.21e-06	1.36e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAT—lung cancer	1.21e-06	1.35e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1A1—lung cancer	1.21e-06	1.35e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.2e-06	1.34e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—lung cancer	1.2e-06	1.34e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ERCC2—lung cancer	1.2e-06	1.34e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—lung cancer	1.2e-06	1.33e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—lung cancer	1.2e-06	1.33e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—lung cancer	1.19e-06	1.32e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAT—lung cancer	1.18e-06	1.32e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—lung cancer	1.18e-06	1.31e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—lung cancer	1.18e-06	1.31e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—lung cancer	1.17e-06	1.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—lung cancer	1.17e-06	1.3e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—lung cancer	1.16e-06	1.29e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—lung cancer	1.15e-06	1.29e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.15e-06	1.28e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—lung cancer	1.14e-06	1.28e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—lung cancer	1.14e-06	1.28e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—lung cancer	1.14e-06	1.27e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—lung cancer	1.14e-06	1.27e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—lung cancer	1.13e-06	1.27e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—lung cancer	1.13e-06	1.27e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—lung cancer	1.13e-06	1.26e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—lung cancer	1.13e-06	1.26e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—lung cancer	1.12e-06	1.25e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—lung cancer	1.12e-06	1.25e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—lung cancer	1.12e-06	1.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—lung cancer	1.12e-06	1.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—POMC—lung cancer	1.11e-06	1.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAT—lung cancer	1.1e-06	1.23e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—lung cancer	1.1e-06	1.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—lung cancer	1.1e-06	1.23e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.1e-06	1.22e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—lung cancer	1.1e-06	1.22e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RAF1—lung cancer	1.1e-06	1.22e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—lung cancer	1.09e-06	1.22e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1A1—lung cancer	1.08e-06	1.21e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CREBBP—lung cancer	1.08e-06	1.21e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—lung cancer	1.08e-06	1.21e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—lung cancer	1.08e-06	1.2e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ERCC2—lung cancer	1.07e-06	1.2e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—lung cancer	1.07e-06	1.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTOR—lung cancer	1.07e-06	1.19e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—lung cancer	1.07e-06	1.19e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—lung cancer	1.07e-06	1.19e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1A1—lung cancer	1.06e-06	1.18e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—lung cancer	1.06e-06	1.18e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—lung cancer	1.05e-06	1.18e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—lung cancer	1.05e-06	1.18e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ERCC2—lung cancer	1.05e-06	1.17e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—lung cancer	1.05e-06	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—lung cancer	1.04e-06	1.16e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—lung cancer	1.04e-06	1.16e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—lung cancer	1.04e-06	1.16e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—lung cancer	1.04e-06	1.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOA1—lung cancer	1.04e-06	1.16e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—lung cancer	1.03e-06	1.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—lung cancer	1.03e-06	1.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—lung cancer	1.01e-06	1.13e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—lung cancer	1.01e-06	1.13e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—lung cancer	1.01e-06	1.13e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.92e-07	1.11e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1A1—lung cancer	9.88e-07	1.1e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—lung cancer	9.82e-07	1.1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ERCC2—lung cancer	9.8e-07	1.09e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—lung cancer	9.75e-07	1.09e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—lung cancer	9.71e-07	1.08e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—lung cancer	9.64e-07	1.08e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—lung cancer	9.46e-07	1.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOA1—lung cancer	9.3e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—lung cancer	9.3e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—lung cancer	9.26e-07	1.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—lung cancer	9.24e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—lung cancer	9.23e-07	1.03e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOA1—lung cancer	9.07e-07	1.01e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—lung cancer	9.04e-07	1.01e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POMC—lung cancer	9e-07	1e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—lung cancer	8.99e-07	1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—lung cancer	8.96e-07	1e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.9e-07	9.94e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—lung cancer	8.9e-07	9.93e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—lung cancer	8.81e-07	9.84e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CREBBP—lung cancer	8.77e-07	9.79e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—lung cancer	8.6e-07	9.6e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—lung cancer	8.57e-07	9.57e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—lung cancer	8.51e-07	9.5e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—lung cancer	8.49e-07	9.47e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—lung cancer	8.48e-07	9.47e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—lung cancer	8.48e-07	9.47e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOA1—lung cancer	8.48e-07	9.46e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—lung cancer	8.44e-07	9.42e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—lung cancer	8.44e-07	9.42e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—lung cancer	8.31e-07	9.28e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—lung cancer	8.29e-07	9.25e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—lung cancer	8.26e-07	9.22e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—lung cancer	8.24e-07	9.2e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—lung cancer	8.13e-07	9.08e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.12e-07	9.06e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POMC—lung cancer	8.08e-07	9.02e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—lung cancer	8.02e-07	8.95e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—lung cancer	7.93e-07	8.86e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—lung cancer	7.9e-07	8.81e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POMC—lung cancer	7.89e-07	8.8e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CREBBP—lung cancer	7.87e-07	8.78e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—lung cancer	7.74e-07	8.64e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—lung cancer	7.74e-07	8.64e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—lung cancer	7.73e-07	8.63e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CREBBP—lung cancer	7.68e-07	8.57e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—lung cancer	7.68e-07	8.57e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—lung cancer	7.51e-07	8.38e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—lung cancer	7.46e-07	8.33e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—lung cancer	7.38e-07	8.24e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—lung cancer	7.38e-07	8.24e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POMC—lung cancer	7.37e-07	8.22e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—lung cancer	7.37e-07	8.22e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—lung cancer	7.28e-07	8.13e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—lung cancer	7.25e-07	8.09e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—lung cancer	7.19e-07	8.03e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—lung cancer	7.18e-07	8.01e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CREBBP—lung cancer	7.18e-07	8.01e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—lung cancer	7.1e-07	7.92e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—lung cancer	6.89e-07	7.69e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—lung cancer	6.89e-07	7.69e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—lung cancer	6.88e-07	7.68e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—lung cancer	6.8e-07	7.59e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—lung cancer	6.72e-07	7.5e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—lung cancer	6.65e-07	7.42e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—lung cancer	6.52e-07	7.28e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—lung cancer	6.5e-07	7.26e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—lung cancer	6.44e-07	7.19e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—lung cancer	6.35e-07	7.09e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—lung cancer	6.32e-07	7.05e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—lung cancer	6.29e-07	7.02e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—lung cancer	6.26e-07	6.99e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—lung cancer	6.03e-07	6.73e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—lung cancer	5.97e-07	6.66e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—lung cancer	5.93e-07	6.62e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—lung cancer	5.88e-07	6.56e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—lung cancer	5.77e-07	6.44e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—lung cancer	5.62e-07	6.27e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—lung cancer	5.62e-07	6.27e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—lung cancer	5.49e-07	6.12e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—lung cancer	5.46e-07	6.09e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—lung cancer	5.36e-07	5.98e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—lung cancer	5.33e-07	5.94e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—lung cancer	5.23e-07	5.84e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—lung cancer	5.12e-07	5.72e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—lung cancer	4.89e-07	5.46e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—lung cancer	4.46e-07	4.98e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—lung cancer	4.42e-07	4.93e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—lung cancer	3.96e-07	4.43e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—lung cancer	3.87e-07	4.32e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—lung cancer	3.62e-07	4.04e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—lung cancer	3.61e-07	4.03e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—lung cancer	3.24e-07	3.62e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—lung cancer	3.16e-07	3.53e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—lung cancer	2.95e-07	3.3e-06	CbGpPWpGaD
